SOLIQUA SOLUTION Canada - English - Health Canada

soliqua solution

sanofi-aventis canada inc - insulin glargine; lixisenatide - solution - 100unit; 33mcg - insulin glargine 100unit; lixisenatide 33mcg - insulins

Soliqua Solution for Injection (Sc) Philippines - English - FDA (Food And Drug Administration)

soliqua solution for injection (sc)

sanofi-aventis philippines, inc. - insulin glargine , lixisenatide - solution for injection (sc) - 3.64 mg (equivalent to 100 units of insulin glargine/33 mcg per ml solution

CANINSULIN INSULIN FOR DOGS AND CATS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

caninsulin insulin for dogs and cats

intervet australia pty limited - insulin - parenteral liquid/solution/suspension - insulin hormone active 40.0 iu/ml - endocrine system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - insulin deficiency

Soliqua SoloStar New Zealand - English - Medsafe (Medicines Safety Authority)

soliqua solostar

sanofi-aventis new zealand limited - insulin glargine 3.6378 mg/ml (100 iu/ml); lixisenatide 0.033 mg/ml - solution for injection - active: insulin glargine 3.6378 mg/ml (100 iu/ml) lixisenatide 0.033 mg/ml excipient: glycerol hydrochloric acid metacresol methionine sodium hydroxide water for injection zinc chloride - soliqua solostar is indicated in combination with metformin for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control when this has not been provided by metformin alone or metformin combined with another oral glucose lowering medicinal product or with basal insulin.

Soliqua SoloStar New Zealand - English - Medsafe (Medicines Safety Authority)

soliqua solostar

sanofi-aventis new zealand limited - insulin glargine 3.6378 mg/ml (100 iu/ml); lixisenatide 0.05 mg/ml - solution for injection - active: insulin glargine 3.6378 mg/ml (100 iu/ml) lixisenatide 0.05 mg/ml excipient: glycerol hydrochloric acid metacresol methionine sodium hydroxide water for injection zinc chloride - soliqua solostar is indicated in combination with metformin for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control when this has not been provided by metformin alone or metformin combined with another oral glucose lowering medicinal product or with basal insulin.

LIXISENATIDE WINTHROP TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE SANOFI lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE SANOFI TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE SANOFI lixisenatide 10 mcg (0.05mg/mL) solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi lixisenatide 10 mcg (0.05mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE WINTHROP lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -